PGI Developed ABC Device To Compete With Ventilator

Chandigarh: In the Bio Medical Instruments and Device Lab of Chandigarh PGI, the institute’s experts have developed a device that is giving tough competition to ventilators. It has been named Artificial Breathing Capability Device (ABCD). After the completion of the clinical trial of the device and getting the patent.

The institute is now preparing to launch it in the market in collaboration with a private company. Dr. Joseph L. Mathew, in-charge of Bio Medical Instruments and Device Lab and Advanced Pediatric Center, said that this device is very effective. Work on it was started in 2018.

After the success of the clinical trial and patent, it has been given to a private company for manufacturing. It is expected that the device will be available in the market soon. The most special thing about this device is that it will cost 50 to 60 thousand rupees to make it, while a ventilator is purchased for 20 to 25 lakh rupees.

Dr. Mathew said that the device does not meet all the standards of a ventilator, but it includes all the necessary standards so that the life of a critical patient can be saved in an emergency.

After the arrival of this device, in case of lack of ventilator, the employee or the patient’s family will not need to press the ambu bag. Dr. Mathew said that the device has been equipped with an electro-mechanical system, with the help of which the machine can be given commands based on the sensor readings. It can be used for children and adults as well as for people suffering from serious lung diseases and in trauma cases. After setting the pressure, it has been connected to an alarm, so that in case of imbalance, information can be received immediately. Along with this, the alarm will ring even if the patient’s condition is critical.

Related Posts

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks